Article Text

Download PDFPDF

14 Effect of platelet-rich plasma injections versus placebo on ankle symptoms and function in ankle osteoarthritis: a randomized clinical trial
  1. Liam Paget1,
  2. Guus Reurink1,
  3. Robert-Jan de Vos2,
  4. Adam Weir2,
  5. Maarten Moen3,
  6. Sita Bierma-Zeinstra2,
  7. Sjoerd Stufkens1,
  8. Gino Kerkhoffs1,
  9. Johannes Tol1
  1. 1Amsterdam UMC, University of Amsterdam, Department of Orthopedic Surgery, Amsterdam Movement Sciences, Academic Center for Evidence-based Sports medicine (ACES), Amsterdam Collaboration for Health and Safety in Sports (ACHSS), AMC/VUmc IOC Research Center, Netherlands
  2. 2Department of Orthopedic Surgery and sports medicine, Erasmus MC University Medical Center, Netherlands
  3. 3Department of Sports Medicine, Bergman Clinics, Netherlands


Introduction There is a lack of effective non-surgical interventions for ankle osteoarthritis. Platelet-rich plasma (PRP) injections are widely used and reported to be beneficial for knee osteoarthritis. We evaluated the efficacy of PRP injections in the management of ankle osteoarthritis.

Materials and Methods In this six-center stratified, block-randomised, double-blind, placebo-controlled trial design we randomly assigned 100 patients to two treatment groups: PRP versus Placebo (saline) injected intra-articular. Patients had talocrural joint space narrowing. The primary outcome measure was the American Orthopaedic Foot and Ankle Society (AOFAS) score at 26 weeks follow-up. Secondary outcome measures included multiple Patient Related Outcome Measures assessing pain, function and quality of life.

Results A total of 48 patients were randomized to the PRP-group and 52 patients to the placebo-group. No patients were lost to follow-up for the primary outcome. Compared to baseline, the mean AOFAS score improved by 10 points in the PRP group (from 63 to 73 points; 95% CI: 6 to 14; p<0.001) and 11 points in the placebo group (from 64 to 75 points; 95% CI: 7 to 15; p<0.001). The adjusted between-group difference over 26 weeks was -1 point (95% CI, -6 to 3; p=0.56). No between group differences were seen for any of the secondary outcome measures. There was one serious adverse events in each group unrelated to the study intervention.

Conclusion In patients with ankle (talocrural) osteoarthritis intra-articular PRP injections compared with placebo injections, did not significantly improve ankle symptoms and function over 26 weeks.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.